Small Pharma
Clinical Trials

Small Pharma, is an innovative neuropharma company exploring the use of psychedelics for ground-breaking treatment of depression. When they were granted the world’s first licence for clinical trials of their DMT molecule, we were determined to share the news beyond the science journals.

In order to reach the diverse audiences of end-users, health professionals, therapists and investors, our press-outreach was individually tailored and targeted. The result was articles in a broad spectrum of national, lifestyle, and financial titles plus significant features in VICE, The Financial Times and The Guardian.